Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
P 3 (2)

Trial Status

Unknown4
Recruiting3
Active Not Recruiting1

Clinical Trials (8)

Showing 8 of 8 trials
NCT05164081Phase 3Active Not Recruiting

Dual vs. Single-Antibiotic Impregnated Cement in Hemiarthroplasty for Femoral Neck Fracture

NCT05660733Recruiting

Study of the Aortic and Large Arterial Vessel Infections

NCT06554041Not ApplicableRecruiting

Soft Tissue Response to Different Restorative Materials Used in Implant Dentistry

NCT04672525Phase 3RecruitingPrimary

Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR

NCT04746001Unknown

Artificial Intelligence in the Diagnosis of Orthopaedic Conditions, Particularly Bone Tumours and Infection

NCT05060952Unknown

Calprotectin in Chronic Prosthetic Joint Infection

NCT04488458Not ApplicableUnknown

Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections

NCT04346875Not ApplicableUnknown

Changing of Dressing for Periprosthetic Joint Infection in Total Knee Arthroplasty

Showing all 8 trials

Research Network

Activity Timeline